Standard BioTools Long Term Debt 2010-2024 | LAB
Standard BioTools long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
| Standard BioTools Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $4 |
| 2022 | $63 |
| 2021 | $64 |
| 2020 | $54 |
| 2019 | $54 |
| 2018 | $172 |
| 2017 | $195 |
| 2016 | $195 |
| 2015 | $195 |
| 2014 | $195 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $1 |
| 2010 | $10 |
| 2009 | $14 |
| Standard BioTools Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2024-12-31 | $0 |
| 2024-09-30 | $0 |
| 2024-06-30 | $0 |
| 2024-03-31 | $0 |
| 2023-12-31 | $4 |
| 2023-09-30 | $60 |
| 2023-06-30 | $61 |
| 2023-03-31 | $62 |
| 2022-12-31 | $63 |
| 2022-09-30 | $64 |
| 2022-06-30 | $65 |
| 2022-03-31 | $100 |
| 2021-12-31 | $64 |
| 2021-09-30 | $64 |
| 2021-06-30 | $54 |
| 2021-03-31 | $54 |
| 2020-12-31 | $54 |
| 2020-09-30 | $54 |
| 2020-06-30 | $54 |
| 2020-03-31 | $54 |
| 2019-12-31 | $54 |
| 2019-09-30 | $50 |
| 2019-06-30 | $50 |
| 2019-03-31 | $50 |
| 2018-12-31 | $172 |
| 2018-09-30 | $169 |
| 2018-06-30 | $167 |
| 2018-03-31 | $164 |
| 2017-12-31 | $195 |
| 2017-09-30 | $195 |
| 2017-06-30 | $195 |
| 2017-03-31 | $195 |
| 2016-12-31 | $195 |
| 2016-09-30 | $195 |
| 2016-06-30 | $195 |
| 2016-03-31 | $195 |
| 2015-12-31 | $195 |
| 2015-09-30 | $196 |
| 2015-06-30 | $196 |
| 2015-03-31 | $196 |
| 2014-12-31 | $195 |
| 2014-09-30 | $195 |
| 2014-06-30 | $195 |
| 2014-03-31 | $195 |
| 2013-12-31 | |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | |
| 2012-12-31 | |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | $1 |
| 2011-09-30 | $3 |
| 2011-06-30 | $5 |
| 2011-03-31 | $6 |
| 2010-12-31 | $10 |
| 2010-09-30 | $12 |
| 2010-06-30 | |
| 2010-03-31 | |
| 2009-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.440B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.134B | 48.53 |
| Tempus AI (TEM) | United States | $6.966B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.050B | 97.25 |
| Inspire Medical Systems (INSP) | United States | $4.470B | 86.83 |
| IRhythm Technologies (IRTC) | United States | $3.223B | 0.00 |
| Privia Health (PRVA) | United States | $2.873B | 215.27 |
| Schrodinger (SDGR) | United States | $1.881B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.839B | 0.00 |
| Enovis (ENOV) | United States | $1.825B | 11.29 |
| Omnicell (OMCL) | United States | $1.418B | 30.59 |
| Phreesia (PHR) | United States | $1.409B | 0.00 |
| Azenta (AZTA) | United States | $1.154B | 53.72 |
| 10x Genomics (TXG) | United States | $0.918B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.568B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.551B | 0.00 |
| Talkspace (TALK) | United States | $0.450B | 267.00 |
| Veradigm (MDRX) | United States | $0.449B | 0.00 |
| TruBridge (TBRG) | United States | $0.363B | 0.00 |
| Claritev (CTEV) | United States | $0.325B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.270B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.189B | 0.00 |
| Pulmonx (LUNG) | United States | $0.182B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.100B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.082B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.076B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.066B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| CareCloud (CCLD) | United States | $0.060B | 2.58 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Syra Health (SYRA) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |